Multi-omic machine learning predictor of breast cancer therapy response SJ Sammut, M Crispin-Ortuzar, SF Chin, E Provenzano, HA Bardwell, ... Nature 601 (7894), 623-629, 2022 | 240 | 2022 |
The genomic and immune landscapes of lethal metastatic breast cancer L De Mattos-Arruda, SJ Sammut, EM Ross, R Bashford-Rogers, ... Cell reports 27 (9), 2690-2708. e10, 2019 | 107 | 2019 |
Auditory temporal-envelope processing in high-functioning children with autism spectrum disorder JI Alcántara, TE Cope, W Cope, EJ Weisblatt Neuropsychologia 50 (7), 1235-1251, 2012 | 61 | 2012 |
Effects of level and frequency on the audibility of partials in inharmonic complex tones BCJ Moore, BR Glasberg, KE Low, T Cope, W Cope The Journal of the Acoustical Society of America 120 (2), 934-944, 2006 | 47 | 2006 |
The association of warthin tumor with salivary ductal inclusions in intra and periparotid lymph nodes W Cope, C Naugler, SM Taylor, J Trites, RD Hart, MJ Bullock Head and neck pathology 8, 73-76, 2014 | 30 | 2014 |
miR-146a and miR-155 expression levels in acute graft-versus-host disease incidence S Atarod, MM Ahmed, C Lendrem, KF Pearce, W Cope, J Norden, ... Frontiers in immunology 7, 56, 2016 | 29 | 2016 |
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants M Messaoudene, TP Mourikis, J Michels, Y Fu, M Bonvalet, ... Annals of Oncology 30 (6), 934-944, 2019 | 25 | 2019 |
The mechanism of balloon Eustachian tuboplasty: a biomechanical study ME Smith, AE Weir, DCC Prior, W Cope, JR Tysome, M Sutcliffe Medical & Biological Engineering & Computing 58, 689-699, 2020 | 18 | 2020 |
A case of necrotising fasciitis caused by Serratia marsescens: extreme age as functional immunosuppression? TE Cope, W Cope, DM Beaumont Age and ageing 42 (2), 266-268, 2013 | 14 | 2013 |
Effect of provision of the NHS NPSA oral anticoagulant therapy patient information pack upon patients’ knowledge and anticoagulant control L Fairbairn‐Smith, W Cope, B Robinson, F Kamali, H Wynne Journal of Thrombosis and Haemostasis 9 (1), 231-233, 2011 | 7 | 2011 |
The diagnosis and management of lobular carcinoma in situ W Cope, E Provenzano Diagnostic Histopathology 29 (3), 153-161, 2023 | 2 | 2023 |
Prevalence of Salivary Ductal Inclusions in Parotid Lymph Nodes of Patients with Warthin Tumor W Cope, CT Naugler, T Vyas, MJ Bullock LABORATORY INVESTIGATION 89, 247A-247A, 2009 | 1 | 2009 |
Expression of transglutaminase-2 (TGM2) in the prognosis of female invasive breast cancer FM Blows, HR Ali, W Cope, PDP Pharoah, CVS Pike, E Provenzano, ... BJC Reports 2 (1), 5, 2024 | | 2024 |
Predicting response to treatment in early breast cancer using dynamic integrative multi-omic profiling SJ Sammut, M Crispin-Ortuzar, SF Chin, E Provenzano, W Cope, ... Cancer Research 82 (12_Supplement), 476-476, 2022 | | 2022 |
Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer with Gene Expression and Computational Pathology W Cope | | 2022 |
Investigation of transglutaminase 2 as a biomarker of invasive breast cancer that is likely to metastasise F Blows, E Provenzano, R Ali, W Cope, P Pharoah, C Pike, P Coussons BRITISH JOURNAL OF CANCER 119 (11), 31-31, 2018 | | 2018 |
MiR-146a and miR-155 expression levels in allogeneic haematopoietic stem cell transplantation patients is predictive of acute graft-versus-host incidence S Atarod, M Ahmed, C Lendrem, K Pearce, W Cope, J Norden, X Wang, ... 41st Annual Meeting of the European Society for Blood and Marrow Transplantation, 2015 | | 2015 |
MiR-146a-5p and its targets in graft-versus-host disease S Atarod, W Cope, J Norden, M Collin, X Wang, A Dickinson BONE MARROW TRANSPLANTATION, 2013 | | 2013 |
miR-146a expression in graft-versus-host disease S Atarod, W Cope, J Norden, M Collin, AM Dickinson 38th Annual Meeting of the European Group for Blood and Marrow …, 2012 | | 2012 |
Role of miR-146a-5p in Graft-versus-Host Disease S Atarod, W Cope, J Norden, M Collin, AM Dickinson European Congress of Immunology, 2012 | | 2012 |